Page last updated: 2024-09-04

5,6-dehydronorketamine and ketamine

5,6-dehydronorketamine has been researched along with ketamine in 7 studies

*Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors. [MeSH]

*Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors. [MeSH]

Compound Research Comparison

Studies
(5,6-dehydronorketamine)
Trials
(5,6-dehydronorketamine)
Recent Studies (post-2010)
(5,6-dehydronorketamine)
Studies
(ketamine)
Trials
(ketamine)
Recent Studies (post-2010) (ketamine)
80115,0292,3216,678

Protein Interaction Comparison

ProteinTaxonomy5,6-dehydronorketamine (IC50)ketamine (IC50)
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)4.216
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)4.216
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)5.02
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)5.02
Glutamate receptor ionotropic, NMDA 1Homo sapiens (human)3.7762
Glutamate receptor ionotropic, NMDA 2AHomo sapiens (human)3.5563
Glutamate receptor ionotropic, NMDA 2BHomo sapiens (human)4.1059
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)5.02
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)5.02
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)5.02

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's3 (42.86)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calvo, MB; Dominguez-Gil, A; Gascon, AR; Hernandez, R; Muriel, C; Pedraz, JL; Torres, LM1
Calvo, MB; Domínguez-Gil, A; Hernández-Arbeiza, J; Lanao, JM; Muriel, C; Pedraz, JL1
Adams, JD; Baillie, TA; Castagnoli, N; Trevor, AJ1
Aucoin, DP; Seay, SS; Tyczkowska, KL1
Bolze, S; Boulieu, R1
Bolon, M; Boulieu, R; Hijazi, Y1
Sandbaumhüter, FA; Theurillat, R; Thormann, W1

Other Studies

7 other study(ies) available for 5,6-dehydronorketamine and ketamine

ArticleYear
Pharmacokinetics and distribution of ketamine after extradural administration to dogs.
    British journal of anaesthesia, 1991, Volume: 67, Issue:3

    Topics: Anesthesia, Epidural; Anesthesia, General; Animals; Biotransformation; Brain; Dogs; Female; Half-Life; Ketamine; Male

1991
Pharmacokinetic and clinical evaluation of ketamine administered by i.v. and epidural routes.
    International journal of clinical pharmacology, therapy, and toxicology, 1987, Volume: 25, Issue:2

    Topics: Adult; Aged; Blood Pressure; Cardiac Output; Half-Life; Humans; Injections, Epidural; Injections, Intravenous; Ketamine; Kinetics; Middle Aged; Respiration

1987
Studies on the biotransformation of ketamine. 1-Identification of metabolites produced in vitro from rat liver microsomal preparations.
    Biomedical mass spectrometry, 1981, Volume: 8, Issue:11

    Topics: Animals; Biotransformation; Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; In Vitro Techniques; Ketamine; Male; Microsomes, Liver; Rats; Rats, Inbred Strains

1981
Rapid high-performance liquid chromatographic method for the determination of ketamine and its metabolite dehydronorketamine in equine serum.
    Journal of chromatography, 1993, Oct-29, Volume: 620, Issue:2

    Topics: Animals; Chromatography, High Pressure Liquid; Horses; Ketamine; Mass Spectrometry; Spectrophotometry, Ultraviolet

1993
HPLC determination of ketamine, norketamine, and dehydronorketamine in plasma with a high-purity reversed-phase sorbent.
    Clinical chemistry, 1998, Volume: 44, Issue:3

    Topics: Acetates; Calibration; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Ketamine; Methylene Chloride; Sensitivity and Specificity; Tilidine

1998
Stability of ketamine and its metabolites norketamine and dehydronorketamine in human biological samples.
    Clinical chemistry, 2001, Volume: 47, Issue:9

    Topics: Blood Specimen Collection; Chromatography, High Pressure Liquid; Humans; Ketamine; Temperature; Time Factors

2001
Separation of hydroxynorketamine stereoisomers using capillary electrophoresis with sulfated β-cyclodextrin and highly sulfated γ-cyclodextrin.
    Electrophoresis, 2017, Volume: 38, Issue:15

    Topics: Animals; beta-Cyclodextrins; Electrophoresis, Capillary; Horses; Humans; Ketamine; Microsomes, Liver; Sulfates

2017